NON-SMALL CELL LUNG CANCER STAGE II
Clinical trials for NON-SMALL CELL LUNG CANCER STAGE II explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER STAGE II trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER STAGE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to stop lung cancer from returning
Disease control OngoingThis study tests whether adding the drug durvalumab to targeted radiation (SBRT) can help keep early-stage non-small cell lung cancer from coming back. It included 13 people with stage I to IIIA disease. The main goal was to see how long they lived without their cancer getting wo…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE II
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:48 UTC
-
New keytruda copycat tested in lung cancer patients
Disease control OngoingThis study compares a new drug, SB27, to the approved cancer medicine Keytruda in people with early-stage non-small cell lung cancer who have already had surgery and chemotherapy. The main goal is to see if SB27 stays in the body the same way as Keytruda. About 163 participants w…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE II
Phase: PHASE1 • Sponsor: Samsung Bioepis Co., Ltd. • Aim: Disease control
Last updated Jun 08, 2026 13:10 UTC